Sun Pharma’s arm to acquire shares of Tarsius Pharma

10 Sep 2018 Evaluate

Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries has agreed to acquire shares of Tarsius Pharma (Tarsius), Israel, by way of subscription of 345,622 ordinary shares of nominal value of NIS 0.01 each, representing 18.75% of shares of Tarsius, on a fully diluted basis.

Tarsius is an Israel based early stage Research and Development (R&D) company focusing on development of drug candidates in the field of Ophthalmology. The cost of acquisition is $3 million and indicative time period for completion of the acquisition is before September 15, 2018.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.


Sun Pharma Inds. Share Price

1700.55 -29.25 (-1.69%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×